Drug Repositioning: New Approaches and Future Prospects for Life-Debilitating Diseases and the COVID-19 Pandemic Outbreak

    September 2020 in “ Viruses ”
    Zheng Yao Low, Isra Ahmad Farouk, Sunil K. Lal
    Studysummary This review highlights that drug repositioning offers a cost-effective alternative to traditional drug discovery, especially for treating orphan and resistant diseases like COVID-19, by repurposing existing drugs such as Hydroxychloroquine and Remdesivir.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on mdpi.com →
    Discuss this study in the Community →

    Research cited in this study 7

    1. Repurposing of Approved Cardiovascular Drugs Journal of Translational Medicine · 2016
    2. Hair Loss in Women: Comprehensive Overview and Treatment Options Seminars in Cutaneous Medicine and Surgery · 2009
    3. Medical Treatments for Male and Female Pattern Hair Loss Journal of The American Academy of Dermatology · 2008
    4. Minoxidil: Mechanisms of Action on Hair Growth British Journal of Dermatology · 2004
    5. Topical Minoxidil Therapy for Androgenetic Alopecia - Reply Archives of Dermatology · 1988
    6. Topical Minoxidil Therapy for Androgenetic Alopecia PubMed · 1988
    7. Minoxidil for Severe Hypertension After Failure of Other Hypotensive Drugs BMJ · 1977

    Related research 1

    1. Need for a Standardized Translational Drug Development Platform: Lessons Learned from the Repurposing of Drugs for COVID-19 Microorganisms · 2022